These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 27983891)
1. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found. Carlson B Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891 [No Abstract] [Full Text] [Related]
2. The Future of Genome Editing. Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947 [TBL] [Abstract][Full Text] [Related]
3. Could CRISPR be the solution for gene editing's Gordian knot? Fang H; Wang W Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448 [No Abstract] [Full Text] [Related]
5. Gene editing based hearing impairment research and therapeutics. Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050 [TBL] [Abstract][Full Text] [Related]
7. [A new toolbox for genome editing]. Jordan B Med Sci (Paris); 2017 Jan; 33(1):105-108. PubMed ID: 28120767 [TBL] [Abstract][Full Text] [Related]
8. A CRISPR edit for heart disease. King A Nature; 2018 Mar; 555(7695):S23-S25. PubMed ID: 29517035 [No Abstract] [Full Text] [Related]
9. The Daunting Economics of Therapeutic Genome Editing. Wilson RC; Carroll D CRISPR J; 2019 Oct; 2(5):280-284. PubMed ID: 31599686 [TBL] [Abstract][Full Text] [Related]
10. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future. Luo J Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053 [No Abstract] [Full Text] [Related]
16. Gene editing using CRISPR-Cas9 for the treatment of lung cancer. Castillo A Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040 [No Abstract] [Full Text] [Related]
17. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9]. Zhou Y; Zong Y; Kong X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230 [TBL] [Abstract][Full Text] [Related]
18. [CRISPR-Cas system as molecular scissors for gene therapy]. Heinz GA; Mashreghi MF Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743 [TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Kim EJ; Kang KH; Ju JH Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282 [TBL] [Abstract][Full Text] [Related]
20. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality. Kofler N; Kraschel KL Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]